IGM Biosciences Inc (NAS:IGMS)
$ 12.3 0.91 (7.99%) Market Cap: 729.62 Mil Enterprise Value: 459.23 Mil PE Ratio: 0 PB Ratio: 5.52 GF Score: 34/100

IGM Biosciences Inc to Discuss IGMS ASH Data - Conference Call Transcript

Dec 12, 2021 / 12:30AM GMT
Operator

Hello, and welcome to the IGM Biosciences Conference Call.

I will turn the call over to Fred Schwarzer, Chief Executive Officer of IGM Biosciences. Fred?

Fred M. Schwarzer
IGM Biosciences, Inc. - CEO, President & Director

Thank you, operator, and welcome to all of you joining us on this call. We greatly appreciate your interest in IGM Biosciences. This presentation will contain certain forward-looking statements based on information available to IGM Biosciences as of today's date, and we must advise you that these forward-looking statements are subject to many factors, which are beyond our control. Caution that these forward-looking statements should not be relied upon as predictions of future events. We also direct you to the risk factors described in our filings with the SEC.

We are honored and pleased to have Dr. Elizabeth Budde, of the city of Hope National Medical Center with us to present the data which she shared at the ASH conference earlier this afternoon. Dr. Budde is one of the world's leaders in the clinical development of T

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot